Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Development in the Chemotherapy of Infectious Diseases caused by Intracellular Pathogenic Protozoa: Trypanosoma and Leishmania

Author(s): Wanderley de Souza

Volume 27, Issue 14, 2021

Published on: 29 April, 2021

Page: [1649 - 1649] Pages: 1

DOI: 10.2174/138161282714210429112726

Next »
[1]
Dean S. Basic Biology of Trypanosoma brucei with Reference to the Development of Chemotherapies. Curr Pharm Des 2021; 27(14): 1650-70.
[2]
Zuma AA, Barrias E. dos S, de Souza W. Basic Biology of Trypanosoma cruzi. Curr Pharm Des 2021; 27(14): 1671-732.
[3]
Taylor MC, Ward AI, Olmo F, et al. Bioluminescent:Fluorescent Trypanosoma cruzi Reporter Strains as Tools for Exploring Chagas Disease Pathogenesis and Drug Activity. Curr Pharm Des 2021; 27(14): 1733-40.
[4]
de Lana M, Giunchetti RC. Dogs as a Model for Chemotherapy of Chagas Disease and Leishmaniasis. Curr Pharm Des 2021; 27(14): 1741-56.
[5]
Chazapi E, Magoulas GE, Prousis KC, Calogeropoulou T. Phospholipid Analogues as Chemotherapeutic Agents Against Trypanosomatids. Curr Pharm Des 2021; 27(15): 1790-806.
[6]
Dantas-Pereira L, Cunha-Junior EF, Andrade-Neto VV. Naphthoquinones and Derivatives for Chemotherapy: Perspectives and Limitations of their Antitrypanosomatids Activities. Curr Pharm Des 2021; 27(15): 1807-24.
[7]
da Gama AN. Silva, Soeiro MNC. Quinoline-based Compounds as Key Candidates to Tackle Drug Discovery Programs of Microbicidal Agents. Curr Pharm Des 2021; 27(15): 1757-62.
[8]
Benaim G, Paniz-Mondolfi AE, Sordillo EM. The Rationale for Use of Amiodarone and its Derivatives for the Treatment of Chagas’ Disease and Leishmaniasis. Curr Pharm Des 2021; 27(15): 1825-33.
[9]
Piñeyro MD, Arias D, Parodi-Talice A, Guerrero S, C Robello. Trypanothione Metabolism as Drug Target for Trypanosomatids. Curr Pharm Des 2021; 27(15): 1834-46.
[10]
M. Navarro. ,, R.M.S. Justo, G.Y.S. Delgado and G. Visbal. Metallodrugs for the Treatment of Trypanosomatid Diseases: Recent Advances and New Insights. Curr Pharm Des 2021; 27(15): 1763-89.

Rights & Permissions Print Cite
Article Metrics
6
1
© 2024 Bentham Science Publishers | Privacy Policy